Preventing Overdoses with Test Strips Act

Bill: 118-hr-5801
Sponsor: full_name: Rep. Gottheimer, Josh [D-NJ-5]
Introduced: 2023-09-28
Policy area: Health
Subjects: Drug trafficking and controlled substances

Health programs administration and funding

Health technology, devices, supplies

Medical tests and diagnostic methods
Latest action: action_date: 2023-09-29
text: Referred to the Subcommittee on Health.

Summaries:

tv_txt: I 118th CONGRESS 1st Session H. R. 5801 IN THE HOUSE OF REPRESENTATIVES September 28, 2023 Mr. Gottheimer (for himself, Mr. Bacon , and Mr. Gallego ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To ensure that expenses relating to the acquisition or use of devices for use in the detection of fentanyl, xylazine, and other emerging adulterant substances, including test strips, are allowable expenses under certain grant programs.

1. Short title This Act may be cited as the Preventing Overdoses with Test Strips Act . 2. Amending the 21st Century Cures Act to authorize the use of funds for devices for use in the detection of fentanyl, xylazine, and other emerging adulterant substances Section 1003 of the 21st Century Cures Act ( 42 U.S.C. 290ee–3a ) is amended— (1) in subsection (b)(4), by adding at the end the following: (G) Providing assistance for expenses relating to the acquisition or use of adulterant substance detection devices. ; and (2) in subsection (h)— (A) by redesignating paragraphs (1) through (4) as paragraphs (2) through (5), respectively; and (B) by inserting before paragraph (2) (as so redesignated), the following: (1) Adulterant substance detection device The term adulterant substance detection device means a device, including a test strip, that can detect the presence of an adulterant, such as fentanyl, xylazine, or another adulterant in a drug sample prior to use of a controlled substance . . 3. Amending the Public Health Service Act to authorize the use of funds for devices for use in the detection of fentanyl, xylazine, and other emerging adulterant substances Part A of title V of the Public Health Service Act ( 42 U.S.C. 290aa et seq. ) is amended by adding at the end the following: 506B. Use of funds for devices for use in the detection of fentanyl, xylazine, and other emerging adulterant substances (a) In general Expenses relating to the acquisition or use of adulterant substance detection devices shall be allowable expenses under any grant, contract, or cooperative agreement entered into by the Substance Abuse and Mental Health Services Administration under this Act. (b) Definition In this section, the term adulterant substance detection device means a device, including a test strip, that can detect the presence of an adulterant, such as fentanyl, xylazine, or another adulterant in a drug sample prior to use of a controlled substance. .